Dana Němcová

2.0k total citations
37 papers, 478 citations indexed

About

Dana Němcová is a scholar working on Hematology, Speech and Hearing and Rheumatology. According to data from OpenAlex, Dana Němcová has authored 37 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 11 papers in Speech and Hearing and 7 papers in Rheumatology. Recurrent topics in Dana Němcová's work include Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (11 papers) and Acute Lymphoblastic Leukemia research (4 papers). Dana Němcová is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (11 papers) and Acute Lymphoblastic Leukemia research (4 papers). Dana Němcová collaborates with scholars based in Czechia, Italy and United States. Dana Němcová's co-authors include Pavla Doležalová, J Hoza, Jaroslav Chládek, Jiří Vencovský, Ali Düzova, Ayşı̇n Bakkaloğlu, E Tunçbilek, Kateřina Jarošová, Nesrin Beşbaş and Seza Özen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

Dana Němcová

37 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Němcová Czechia 13 180 125 120 88 80 37 478
Elżbieta Smolewska Poland 12 220 1.2× 37 0.3× 123 1.0× 91 1.0× 121 1.5× 73 466
Laurent Pérard France 16 174 1.0× 248 2.0× 214 1.8× 75 0.9× 102 1.3× 34 823
Anne Lohse France 15 73 0.4× 91 0.7× 220 1.8× 50 0.6× 90 1.1× 39 723
Oya Köker Türkiye 11 126 0.7× 57 0.5× 55 0.5× 144 1.6× 76 0.9× 43 329
Jean Louis Stéphan France 12 183 1.0× 50 0.4× 27 0.2× 53 0.6× 63 0.8× 32 487
Cristina Rosário Portugal 6 323 1.8× 34 0.3× 185 1.5× 71 0.8× 131 1.6× 10 603
X Tena Spain 13 170 0.9× 72 0.6× 478 4.0× 68 0.8× 70 0.9× 38 868
Miroslav Harjaček Croatia 11 162 0.9× 43 0.3× 109 0.9× 126 1.4× 135 1.7× 40 419
Fatih Haşlak Türkiye 12 109 0.6× 60 0.5× 55 0.5× 152 1.7× 99 1.2× 59 425
Mustafa Çakan Türkiye 14 132 0.7× 102 0.8× 113 0.9× 302 3.4× 176 2.2× 83 590

Countries citing papers authored by Dana Němcová

Since Specialization
Citations

This map shows the geographic impact of Dana Němcová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Němcová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Němcová more than expected).

Fields of papers citing papers by Dana Němcová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Němcová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Němcová. The network helps show where Dana Němcová may publish in the future.

Co-authorship network of co-authors of Dana Němcová

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Němcová. A scholar is included among the top collaborators of Dana Němcová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Němcová. Dana Němcová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krůtová, Marcela, Václav Čapek, Pavel Čermák, et al.. (2020). The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients. Antimicrobial Resistance and Infection Control. 9(1). 98–98. 14 indexed citations
2.
Kieslichová, Eva, et al.. (2019). Single mutidrug resistant enterobacteriacae donor-derived infection in four solid organ transplant recipients: a case report. BMC Surgery. 19(1). 111–111. 6 indexed citations
3.
Němcová, Dana, et al.. (2019). AB0965 PAEDIATRIC SARCOIDOSIS: A PROFESSIONAL IMITATOR. Annals of the Rheumatic Diseases. 78. 1948–1949. 1 indexed citations
4.
Doležalová, Pavla, Marek Böhm, Dana Němcová, et al.. (2018). The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 38(S1). 123–130. 1 indexed citations
5.
Constantin, T., Nataša Toplak, Christof Iking‐Konert, et al.. (2017). Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring.. PubMed. 34 Suppl 100(5). 200–206. 16 indexed citations
6.
Fráňová, Jana, et al.. (2016). Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Pediatric Rheumatology. 14(1). 36–36. 30 indexed citations
7.
Kubánek, Miloš, Jiří Kettner, Tomáš Kotulák, et al.. (2015). Changing profile of infective endocarditis in patients hospitalised in a tertiary Czech hospital from 2000 to 2013. Cor et Vasa. 58(6). e576–e583. 3 indexed citations
8.
Lovell, Daniel J., Nicolino Ruperto, Kateřina Jarošová, et al.. (2014). A52: The Impact of Adalimumab on Growth in Patients With Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 66(S3). 1 indexed citations
9.
Król, Petra, et al.. (2014). PFAPA syndrome: clinical characteristics and treatment outcomes in a large single-centre cohort.. PubMed. 31(6). 980–7. 36 indexed citations
10.
Ruperto, Nicolino, D. Lovell, Kateřina Jarošová, et al.. (2013). PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis. Pediatric Rheumatology. 11(S2). 1 indexed citations
11.
12.
13.
Martini, Giorgia, Fabio Vittadello, Özgür Kasapçopur, et al.. (2008). Factors affecting survival in juvenile systemic sclerosis. Lara D. Veeken. 48(2). 119–122. 55 indexed citations
14.
Viklický, Ondřej, et al.. (2007). The incidence of infectious diseases after renal transplantation: a single-centre experience. International Journal of Antimicrobial Agents. 31. 58–62. 19 indexed citations
15.
Kutílek, Štěpán, M Bayer, Pavla Doležalová, & Dana Němcová. (2006). Quantitative ultrasonometry of the calcaneus in children with juvenile idiopathic arthritis. Lara D. Veeken. 45(10). 1273–1275. 7 indexed citations
16.
Němcová, Dana & Pavel Novák. (2003). Adoption of Dogs in the Czech Republic. Acta Veterinaria Brno. 72(3). 421–427. 14 indexed citations
17.
Doležalová, Pavla, et al.. (2003). Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations.. PubMed. 20(2). 249–54. 13 indexed citations
18.
Özen, Seza, Mehmet Alikaşifoğlu, Ayşı̇n Bakkaloğlu, et al.. (2002). Tumour necrosis factor α G→A −238 and G→A −308 polymorphisms in juvenile idiopathic arthritis. Lara D. Veeken. 41(2). 223–227. 68 indexed citations
19.
Hampl, Richard, Oldřich Lapčı́k, J Šulcová, et al.. (1994). The effect of long-term glucocorticoid therapy on glucocorticoid receptor content and on steroid response to ACTH. The Journal of Steroid Biochemistry and Molecular Biology. 48(1). 81–87. 4 indexed citations
20.
Bayer, M, J Štěpán, Dana Němcová, Štěpán Kutílek, & J Hoza. (1994). Juvenile chronic arthritis--bone mineral density in relation to corticosteroid therapy.. PubMed. 40(1-4). 33–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elżbieta Smolewska Breakdown of academic impact, for papers by Laurent Pérard Breakdown of academic impact, for papers by Anne Lohse Breakdown of academic impact, for papers by Oya Köker Breakdown of academic impact, for papers by Jean Louis Stéphan Breakdown of academic impact, for papers by Cristina Rosário Breakdown of academic impact, for papers by X Tena Breakdown of academic impact, for papers by Miroslav Harjaček Breakdown of academic impact, for papers by Fatih Haşlak Breakdown of academic impact, for papers by Mustafa Çakan
Rankless by CCL
2026